A Monsanto research facility in Connecticut that’s slated to close later this year may be converted into a medical marijuana grow site.
A pair of MMJ companies have already made inquiries about possibly acquiring the facility, local official Rob Simmons from the town of Stonington told news outlet the Day.
Simmons said he advised both companies to contact the state and Monsanto to ask about zoning and permits and whether the company would be interested in selling the facility, which is located in the town of Mystic.
The facility is 79,000 square feet, including a 28,000 greenhouse. Though no specific closure date has been announced, Monsanto said it will be done in two phases beginning in late October.
No other plans aside from growing medical cannabis have been revealed, but Monsanto has indicated in the past that it would be selling the facility, the Day reported.
On Wednesday, German pharmaceutical and chemicals giant Bayer said it hammered out an agreement to acquire Monsanto in a deal valued at $66 billion.